Barclays
NXL icon

Barclays’s Nexalin Technology NXL Stock Holding History

Barclays’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80 Buy
+8
New +$99 ﹤0.01% 5210

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Barclays's NXL Position: Q2 2026 in Review

Barclays opened a new position in Nexalin Technology (NXL) in Q2 2026: 8 shares worth $80. The stake represents ﹤0.01% of the portfolio and ranks #5210 among its holdings.

20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Barclays held 8 shares of Nexalin Technology worth $80 as of Q2 2026.
  • Nexalin Technology was a new Barclays position in Q2 2026.
  • Nexalin Technology made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5210 holding.
  • 20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.